Background Safety data on 'real‐life'allergen immunotherapy (AIT) in children and
adolescents is usually extrapolated from studies in adults. Methods Patients aged 18 or …

The objective of “Allergen immunotherapy: a practice parameter” is to improve the practice of
allergen immunotherapy for patients with allergic rhinitis, allergic asthma, and Hymenoptera …

Allergen immunotherapy (AIT) is an effective treatment strategy for allergic diseases and has
been used for more than 100 years. In recent years, however, the expectations on concepts …

Allergy immunotherapy (AIT) is an effective treatment for allergic asthma and rhinitis, as well
as venom-induced anaphylaxis. In addition to reducing symptoms, AIT can change the …

This paper was produced to establish a common European Standard for Practical Allergen-
Specific Immunotherapy that could serve as an overall Ôgold standardÕ to ensure optimum …

Information for Category 1 CME Credit Credit can now be obtained, free for a limited time, by
reading the review articles in this issue. Please note the following instructions. Method of …

Subcutaneous immunotherapy and sublingual immunotherapy are beneficial in treating
allergic rhinitis and venom hypersensitivity but should be administered only by physicians …

Allergen immunotherapy is effective for the treatment of allergic rhinitis, allergic asthma, and
Hymenoptera venom allergy. In view of potential side effects, cost, and the necessary patient …

Background Allergen specific immunotherapy has long been a controversial treatment for
asthma. Although beneficial effects upon clinically relevant outcomes have been …

OBJECTIVES: Summarize and update current evidence for the efficacy and safety of
subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) in pediatric …